Coronary artery disease and percutaneous coronary intervention in patients with severe chronic kidney disease
Progress in Cardiovascular Diseases · 2025
DOI: 10.1016/j.pcad.2024.12.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Progress in Cardiovascular Diseases, 2025. Verfasst von Doosup Shin und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, St Francis Hospital and Heart Center, Roslyn, New York, USA. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Renal Insufficiency, Chronic, Coronary Artery Disease, Contrast Media. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Coronary artery disease (CAD) is the leading cause of mortality among patients with chronic kidney disease (CKD), presenting unique challenges in diagnosis and management. Advanced CKD patients often present with atypical symptoms, and conventional diagnostic and interventional approaches carry risks, including contrast-induced nephropathy and the potential need for renal replacement therapy. These risks have led to the phenomenon of "renalism," where necessary procedures may be deferred due to concerns over renal injury. Emerging techniques, such as ultra-low contrast angiography (ULCA) and zero-contrast percutaneous coronary intervention (PCI), offer promising solutions by minimizing or eliminating contrast exposure. This review discusses the clinical presentation of CAD in CKD patients, limitations of traditional diagnostic approaches, and the challenges in managing these high-risk patients. It also provides an overview of ULCA and zero-contrast PCI techniques, which have shown both safety and feasibility even in complex cases. As these techniques continue to evolve, zero-contrast PCI holds the potential to become an essential component of revascularization strategies for high-risk CKD patients, enhancing procedural safety while maintaining therapeutic efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, St Francis Hospital and Heart Center, Roslyn, New York, USA.
- Department of Cardiology, St Francis Hospital and Heart Center, Roslyn, New York, USA; New York Institute of Technology, Old Westbury, New York, USA.
- Baylor Scott & White The Heart Hospital - Plano, Plano, Texas, United States of America.
- Massachusetts General Hospital, Boston, MA, United States of America.
- Department of Cardiology, St Francis Hospital and Heart Center, Roslyn, New York, USA; New York Institute of Technology, Old Westbury, New York, USA. Electronic address: ziad.ali@dcvi.org.
Zitieren
APA
Shin, D., Galougahi, K. K., Singh, M., Caron, E., Cannata, M., Ciftcikal, Y., Gujja, M., Sakai, K., Moses, J., Shlofmitz, R., Al-Azizi, K., Doshi, D., Jeremias, A., Shlofmitz, E., & Ali, Z. A. (2025). Coronary artery disease and percutaneous coronary intervention in patients with severe chronic kidney disease. Progress in Cardiovascular Diseases. https://doi.org/10.1016/j.pcad.2024.12.004
Vancouver
Shin D, Galougahi KK, Singh M, Caron E, Cannata M, Ciftcikal Y, et al. Coronary artery disease and percutaneous coronary intervention in patients with severe chronic kidney disease. Progress in Cardiovascular Diseases. 2025. doi:10.1016/j.pcad.2024.12.004
BibTeX
@article{Shin2025,
author = {Shin, Doosup and Galougahi, Keyvan Karimi and Singh, Mandeep and Caron, Emma and Cannata, Matthew and Ciftcikal, Yasemin and Gujja, Misha and Sakai, Koshiro and Moses, Jeffrey and Shlofmitz, Richard and Al-Azizi, Karim and Doshi, Darshan and Jeremias, Allen and Shlofmitz, Evan and Ali, Ziad A},
title = {Coronary artery disease and percutaneous coronary intervention in patients with severe chronic kidney disease},
journal = {Progress in Cardiovascular Diseases},
year = {2025},
doi = {10.1016/j.pcad.2024.12.004}
}
EUVIMED